Safety of New Formulation of Glatiramer Acetate

Clinical trial NCT00947752 · COMPLETED

Trial details

NCT number: NCT00947752
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Relapsing Remitting Multiple Sclerosis

Start date: 2009-07-01
Primary completion: 2009-09-01
Enrollment: 147

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.